Nuformix
NFX · Main Market · Health Care · mcap £3.6m · 0.1p
Financials · LTM to 31 Mar 26
Source: results 28 May 26 ↗
- Revenue
- £0k
- Operating profit
- −£630k
- Net income
- −£622k
- Free cash flow
- −£619k
- Net cash
- £930k
- Market cap
- £3.3m
- EV / EBIT
- –
- FCF yield
- −19.0%
- Price / book
- 2.0×
Latest half-year · H1 Mar 26 vs H1 Mar 25
results 28 May 26 ↗
- Revenue
- £0k prior £0k
- Operating profit
- −£347k prior −£377k
- Net income
- −£347k prior −£377k
- Cash from operations
- −£395k prior −£391k
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Latest report: H1 Mar 26 (six months to 31 Mar 26), published 28 May 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| LTM Mar 26 | FY Sep 25 | FY Sep 24 | |
|---|---|---|---|
| Revenue | 0.0 | 0.0 | – |
| Gross profit | – | 0.0 | 0.0 |
| Exceptional / adjusting items | – | 0.0 | (3.1) |
| Operating profit | (0.6) | (0.7) | (3.6) |
| Amortisation | 0.0 | 0.0 | 0.0 |
| Profit before tax | (0.6) | (0.7) | (3.6) |
| Tax | 0.0 | 0.0 | 0.0 |
| Net income (owners) | (0.6) | (0.7) | (3.6) |
| EPS basic | (0.0p) | (0.0p) | (0.5p) |
| EPS diluted | (0.0p) | (0.0p) | (0.5p) |
| Latest Mar 26 | FY Sep 25 | FY Sep 24 | |
|---|---|---|---|
| Goodwill | – | 0.9 | 0.9 |
| Other intangibles | 0.9 | 0.9 | – |
| Trade receivables | 0.0 | 0.0 | 0.0 |
| Cash | 0.9 | 0.1 | 0.0 |
| Current assets | 1.0 | 0.1 | 0.1 |
| Total assets | 1.9 | 1.0 | 1.0 |
| Trade payables | 0.2 | 0.3 | 0.3 |
| Current liabilities | 0.2 | 0.3 | 0.3 |
| Total equity | 1.6 | 0.8 | 0.7 |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.